Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Vanderbilt University
With
Gilead Sciences
Eligible participants with known or suspected Pulmonary Hypertension undergoing a clinically indicated right heart catheterization may be enrolled. Clinical data and blood samples will be analyzed.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age ≥ 18 years old
Undergoing RHC for PH evaluation
You may not be if
Anemia defined as Hgb \< 10 g/dL and HCT \< 30
Pregnancy at the time of RHC (as assessed by urine or serum pregnancy test on the day of the procedure)
Left ventricular ejection fraction ≤ 40%
Atrial fibrillation at the time of RHC (as defined by telemetry monitoring or EKG on the day of the procedure)
IPF, CTEPH, COPD/OSA as the dominant etiology of PH
Patient is currently taking PH medication or long-acting nitrates at the time of their RHC.
